Table 1: Baseline characteristics of the included patients.
Variable |
Letrozole (Group A) |
Letrozole plus Gonadotropin (Group B) |
Total |
P-value¥ |
|||
(n = 45) |
(n = 45) |
(n = 90) |
|||||
Mean |
Standard Deviation |
Mean |
Standard Deviation |
Mean |
Standard Deviation |
||
Age (year) |
27.3 |
3.6 |
25 |
3 |
26.1 |
3.5 |
0.002* |
BMI (kg/m2) |
28 |
1.8 |
28.8 |
2.3 |
28.3 |
2.1 |
0.091 |
Prior Infertility period (year) |
2.6 |
1 |
2.6 |
0.7 |
2.6 |
0.8 |
0.731 |
FSH (mIU/mL) |
5.8 |
1.3 |
5.8 |
0.9 |
5.8 |
1.1 |
0.993 |
Progesterone (ng/mL) |
1.9 |
0.7 |
1.8 |
0.7 |
1.8 |
0.7 |
0.26 |
LH (IU/L) |
6.2 |
1.3 |
6.2 |
0.9 |
6.2 |
1.1 |
0.948 |
Baseline E2 (pg/mL) |
53.8 |
9.9 |
50.4 |
16.6 |
52.1 |
13.7 |
0.248 |
Prolactin (ng/mL) |
13.6 |
3.1 |
15 |
4.1 |
14.3 |
3.7 |
0.127 |
TSH (mU/L) |
2.3 |
0.8 |
2.1 |
0.5 |
2.2 |
0.7 |
0.4 |
¥Mann-Whitney U test; *Significant P-value